The MRDR reaches another milestone of recruiting more than 6500 patients!
Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.
MY-PROMPT-2 project randomises first patient and enrols another!
Ken Lim's paper on Inferior outcomes in t(11;14) multiple myeloma has been accepted for publication.
Congratulations on recruiting >6000 patients on the MRDR!!!
Paper on the second revision of the International Staging System (R2-ISS) accepted for publication!
The MRDR was recently represented at the 4th National Myeloma Workshop.